Global Carcinoid Syndrome Management Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 120 pages | ID: G029638DBDDGEN
GlobalInfoResearch

Abstracts

Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor.

SCOPE OF THE REPORT:

This report studies the Carcinoid Syndrome Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Carcinoid Syndrome Management market by product type and applications/end industries.
The management or treatment of carcinoid syndrome often requires palliative and supportive care. Management of carcinoid syndrome involves drug therapy or surgical removal of carcinoid tumor from the organ.
The global Carcinoid Syndrome Management market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Carcinoid Syndrome Management.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers

• Novartis
• Omega Laboratories
• Teva Pharmaceutical
• Mylan
• Ipsen Biopharmaceuticals
• Sirtex Medical
• BTG International
• Wockhardt
• Sun Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Chemotherapy
• Biological Therapy
• Hepatic Artery Embolization Agents

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Cancer Institute and Treatment Centers

Contents

1 CARCINOID SYNDROME MANAGEMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Carcinoid Syndrome Management
1.2 Classification of Carcinoid Syndrome Management by Types
  1.2.1 Global Carcinoid Syndrome Management Revenue Comparison by Types (2017-2023)
  1.2.2 Global Carcinoid Syndrome Management Revenue Market Share by Types in 2017
  1.2.3 Chemotherapy
  1.2.4 Biological Therapy
  1.2.5 Hepatic Artery Embolization Agents
1.3 Global Carcinoid Syndrome Management Market by Application
  1.3.1 Global Carcinoid Syndrome Management Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Cancer Institute and Treatment Centers
1.4 Global Carcinoid Syndrome Management Market by Regions
  1.4.1 Global Carcinoid Syndrome Management Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Carcinoid Syndrome Management Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Carcinoid Syndrome Management Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Carcinoid Syndrome Management Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Carcinoid Syndrome Management Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Carcinoid Syndrome Management Status and Prospect (2013-2023)
1.5 Global Market Size of Carcinoid Syndrome Management (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Business Overview
  2.1.2 Carcinoid Syndrome Management Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novartis Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.2 Omega Laboratories
  2.2.1 Business Overview
  2.2.2 Carcinoid Syndrome Management Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Omega Laboratories Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical
  2.3.1 Business Overview
  2.3.2 Carcinoid Syndrome Management Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Teva Pharmaceutical Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
  2.4.1 Business Overview
  2.4.2 Carcinoid Syndrome Management Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Mylan Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ipsen Biopharmaceuticals
  2.5.1 Business Overview
  2.5.2 Carcinoid Syndrome Management Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Ipsen Biopharmaceuticals Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sirtex Medical
  2.6.1 Business Overview
  2.6.2 Carcinoid Syndrome Management Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Sirtex Medical Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.7 BTG International
  2.7.1 Business Overview
  2.7.2 Carcinoid Syndrome Management Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 BTG International Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.8 Wockhardt
  2.8.1 Business Overview
  2.8.2 Carcinoid Syndrome Management Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Wockhardt Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sun Pharmaceutical
  2.9.1 Business Overview
  2.9.2 Carcinoid Syndrome Management Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Sun Pharmaceutical Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CARCINOID SYNDROME MANAGEMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Carcinoid Syndrome Management Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Carcinoid Syndrome Management Players Market Share
  3.2.2 Top 10 Carcinoid Syndrome Management Players Market Share
3.3 Market Competition Trend

4 GLOBAL CARCINOID SYNDROME MANAGEMENT MARKET SIZE BY REGIONS

4.1 Global Carcinoid Syndrome Management Revenue and Market Share by Regions
4.2 North America Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
4.3 Europe Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
4.5 South America Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CARCINOID SYNDROME MANAGEMENT REVENUE BY COUNTRIES

5.1 North America Carcinoid Syndrome Management Revenue by Countries (2013-2018)
5.2 USA Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
5.3 Canada Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
5.4 Mexico Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)

6 EUROPE CARCINOID SYNDROME MANAGEMENT REVENUE BY COUNTRIES

6.1 Europe Carcinoid Syndrome Management Revenue by Countries (2013-2018)
6.2 Germany Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
6.3 UK Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
6.4 France Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
6.5 Russia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
6.6 Italy Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC CARCINOID SYNDROME MANAGEMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Carcinoid Syndrome Management Revenue by Countries (2013-2018)
7.2 China Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
7.3 Japan Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
7.4 Korea Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
7.5 India Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA CARCINOID SYNDROME MANAGEMENT REVENUE BY COUNTRIES

8.1 South America Carcinoid Syndrome Management Revenue by Countries (2013-2018)
8.2 Brazil Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
8.3 Argentina Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
8.4 Colombia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE CARCINOID SYNDROME MANAGEMENT BY COUNTRIES

9.1 Middle East and Africa Carcinoid Syndrome Management Revenue by Countries (2013-2018)
9.2 Saudi Arabia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
9.3 UAE Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
9.4 Egypt Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
9.5 Nigeria Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
9.6 South Africa Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)

10 GLOBAL CARCINOID SYNDROME MANAGEMENT MARKET SEGMENT BY TYPE

10.1 Global Carcinoid Syndrome Management Revenue and Market Share by Type (2013-2018)
10.2 Global Carcinoid Syndrome Management Market Forecast by Type (2018-2023)
10.3 Chemotherapy Revenue Growth Rate (2013-2023)
10.4 Biological Therapy Revenue Growth Rate (2013-2023)
10.5 Hepatic Artery Embolization Agents Revenue Growth Rate (2013-2023)

11 GLOBAL CARCINOID SYNDROME MANAGEMENT MARKET SEGMENT BY APPLICATION

11.1 Global Carcinoid Syndrome Management Revenue Market Share by Application (2013-2018)
11.2 Carcinoid Syndrome Management Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Cancer Institute and Treatment Centers Revenue Growth (2013-2018)

12 GLOBAL CARCINOID SYNDROME MANAGEMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Carcinoid Syndrome Management Market Size Forecast (2018-2023)
12.2 Global Carcinoid Syndrome Management Market Forecast by Regions (2018-2023)
12.3 North America Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
12.4 Europe Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
12.6 South America Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Carcinoid Syndrome Management Picture
Table Product Specifications of Carcinoid Syndrome Management
Table Global Carcinoid Syndrome Management and Revenue (Million USD) Market Split by Product Type
Figure Global Carcinoid Syndrome Management Revenue Market Share by Types in 2017
Figure Chemotherapy Picture
Figure Biological Therapy Picture
Figure Hepatic Artery Embolization Agents Picture
Table Global Carcinoid Syndrome Management Revenue (Million USD) by Application (2013-2023)
Figure Carcinoid Syndrome Management Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Cancer Institute and Treatment Centers Picture
Table Global Market Carcinoid Syndrome Management Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Carcinoid Syndrome Management Type and Applications
Table Novartis Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Omega Laboratories Basic Information, Manufacturing Base and Competitors
Table Omega Laboratories Carcinoid Syndrome Management Type and Applications
Table Omega Laboratories Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Carcinoid Syndrome Management Type and Applications
Table Teva Pharmaceutical Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Carcinoid Syndrome Management Type and Applications
Table Mylan Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ipsen Biopharmaceuticals Carcinoid Syndrome Management Type and Applications
Table Ipsen Biopharmaceuticals Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Sirtex Medical Basic Information, Manufacturing Base and Competitors
Table Sirtex Medical Carcinoid Syndrome Management Type and Applications
Table Sirtex Medical Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table BTG International Basic Information, Manufacturing Base and Competitors
Table BTG International Carcinoid Syndrome Management Type and Applications
Table BTG International Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Carcinoid Syndrome Management Type and Applications
Table Wockhardt Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Carcinoid Syndrome Management Type and Applications
Table Sun Pharmaceutical Carcinoid Syndrome Management Revenue, Gross Margin and Market Share (2016-2017)
Table Global Carcinoid Syndrome Management Revenue (Million USD) by Players (2013-2018)
Table Global Carcinoid Syndrome Management Revenue Share by Players (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Share by Players in 2016
Figure Global Carcinoid Syndrome Management Revenue Share by Players in 2017
Figure Global Top 5 Players Carcinoid Syndrome Management Revenue Market Share in 2017
Figure Global Top 10 Players Carcinoid Syndrome Management Revenue Market Share in 2017
Figure Global Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Carcinoid Syndrome Management Revenue (Million USD) by Regions (2013-2018)
Table Global Carcinoid Syndrome Management Revenue Market Share by Regions (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Market Share by Regions (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Market Share by Regions in 2017
Figure North America Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Europe Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure South America Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Table North America Carcinoid Syndrome Management Revenue by Countries (2013-2018)
Table North America Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure North America Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure North America Carcinoid Syndrome Management Revenue Market Share by Countries in 2017
Figure USA Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Canada Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Mexico Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Table Europe Carcinoid Syndrome Management Revenue (Million USD) by Countries (2013-2018)
Figure Europe Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure Europe Carcinoid Syndrome Management Revenue Market Share by Countries in 2017
Figure Germany Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure UK Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure France Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Russia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Italy Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Carcinoid Syndrome Management Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Carcinoid Syndrome Management Revenue Market Share by Countries in 2017
Figure China Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Japan Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Korea Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure India Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Table South America Carcinoid Syndrome Management Revenue by Countries (2013-2018)
Table South America Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure South America Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure South America Carcinoid Syndrome Management Revenue Market Share by Countries in 2017
Figure Brazil Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Argentina Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Colombia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Carcinoid Syndrome Management Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Carcinoid Syndrome Management Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Carcinoid Syndrome Management Revenue Market Share by Countries in 2017
Figure Saudi Arabia Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure UAE Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Egypt Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure Nigeria Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Figure South Africa Carcinoid Syndrome Management Revenue and Growth Rate (2013-2018)
Table Global Carcinoid Syndrome Management Revenue (Million USD) by Type (2013-2018)
Table Global Carcinoid Syndrome Management Revenue Share by Type (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Share by Type (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Share by Type in 2017
Table Global Carcinoid Syndrome Management Revenue Forecast by Type (2018-2023)
Figure Global Carcinoid Syndrome Management Market Share Forecast by Type (2018-2023)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Figure Global Biological Therapy Revenue Growth Rate (2013-2018)
Figure Global Hepatic Artery Embolization Agents Revenue Growth Rate (2013-2018)
Table Global Carcinoid Syndrome Management Revenue by Application (2013-2018)
Table Global Carcinoid Syndrome Management Revenue Share by Application (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Share by Application (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue Share by Application in 2017
Table Global Carcinoid Syndrome Management Revenue Forecast by Application (2018-2023)
Figure Global Carcinoid Syndrome Management Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Cancer Institute and Treatment Centers Revenue Growth Rate (2013-2018)
Figure Global Carcinoid Syndrome Management Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Carcinoid Syndrome Management Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Carcinoid Syndrome Management Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
Figure Europe Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
Figure South America Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Carcinoid Syndrome Management Revenue Market Forecast (2018-2023)